1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 232 F.Supp.3d
  5. 232 F.Supp.3d 636 (2017)
 

ASTRAZENECA AB v. AUROBINDO PHARMA LTD.

C.A. No. 14-664-GMS.

232 F.Supp.3d 636 (2017)

ASTRAZENECA AB, Plaintiff, v. AUROBINDO PHARMA LTD., et al. Defendants.

United States District Court, D. Delaware.

Signed February 2, 2017.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER

Attorney(s) appearing for the Case

Michael P. Kelly, Benjamin A. Smyth, Daniel J. Brown, Daniel M. Silver, McCarter & English, LLP, Wilmington, DE, John D. Livingstone, M. David Weingarten, Maximilienne Bishop, Charles E. Lipsey, Dominick T. Gattuso, Heyman Enerio Gattuso & Hirzel LLP, Wilmington, DE, Laura A. Lydigsen, Ralph J. Gabric, Yun Wei, for Plaintiff.

Kenneth Laurence Dorsney, Morris James LLP, Wilmington, DE, Gina M. Bassi, Sailesh K. Patel, for Defendants.

MEMORANDUM

I. INTRODUCTION

In this consolidated patent infringement action, plaintiff AstraZeneca alleges that pharmaceutical products proposed by defendants Aurobindo Pharma Ltd., Aurobindo Pharma U.S.A., Wockhardt Bio AG, Wochardt USA LLC, Amneal Pharmaceuticals...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases